Meloxicam and Mircette drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Meloxicam (meloxicam) and Mircette (desogestrel; ethinyl estradiol). Common drug interactions include hypertension among females.

The phase IV clinical study analyzes what interactions people have when they take Meloxicam and Mircette. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Meloxicam?

Meloxicam has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 68,016 Meloxicam users. Check the latest studies of Meloxicam.

What is Mircette?

Mircette has active ingredients of desogestrel; ethinyl estradiol. It is often used in birth control. eHealthMe is studying from 465 Mircette users. Check the latest studies of Mircette.

On Jul, 06, 2026

17 people who take Meloxicam and Mircette together, and have interactions are studied.

Meloxicam and Mircette drug interactions.

What are the common drug interactions of Meloxicam and Mircette, by gender? *:

female:

Hypertension (high blood pressure)
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Anaemia (lack of blood)
Arrhythmia (irregular heartbeat)
Arthralgia (joint pain)
Aspartate aminotransferase increased
Asthma
Bacterial infection
Blood bilirubin increased
Breast enlargement

male:

n/a

What are the common drug interactions of Meloxicam and Mircette, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Cholecystitis chronic (long lasting infection of gallbladder)
Gallbladder disorder
Post procedural diarrhoea

30-39:

Lymphocytic hypophysitis (inflammation of the pituitary gland)
Migraine (headache)
Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
Pituitary tumour benign
Polyuria (production of too much dilute urine)
Proteinuria (presence of protein in the urine)
Psychomotor hyperactivity (feelings of extreme restlessness)
Rash
Abdominal discomfort
Abnormal behaviour

40-49:

n/a

50-59:

n/a

60+:

Chronic kidney disease
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 14 people, 82.35%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 12 people, 70.59%
Sinusitis (inflammation of sinus): 6 people, 35.29%
Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain): 3 people, 17.65%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.76%
High Blood Cholesterol: 2 people, 11.76%
Drowsiness: 2 people, 11.76%
Migraine (headache): 2 people, 11.76%
Asthma: 2 people, 11.76%
Oedema (fluid collection in tissue): 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Meloxicam and Mircette?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously